Search
Menu
Hamamatsu Corp. - Earth Innovations LB 2/24

Biomagnetics Diagnostics Corp.

Facebook X LinkedIn Email
Biomagnetics Diagnostics Corp., based in Orangevale, Calif., has accepted delivery of a biosensor that is proposed for use in diagnosing cholera, tuberculosis and malaria. The sensor could be in clinical trials by 2012. Developed in conjunction with scientists and engineers at Los Alamos National Laboratory in New Mexico, the device could allow relatively untrained medical personnel to detect a variety of diseases rapidly. It uses planar waveguides to bring protein-receptor pairs into proximity with one another, thus triggering detectable fluorescence. The company plans to commercialize the sensor, which was created through a cooperative research and development agreement with Los Alamos National Security LLC.
Rocky Mountain Instruments - Custom Assemblies MR

Published: September 2011
Glossary
fluorescence
Fluorescence is a type of luminescence, which is the emission of light by a substance that has absorbed light or other electromagnetic radiation. Specifically, fluorescence involves the absorption of light at one wavelength and the subsequent re-emission of light at a longer wavelength. The emitted light occurs almost instantaneously and ceases when the excitation light source is removed. Key characteristics of fluorescence include: Excitation and emission wavelengths: Fluorescent materials...
AmericasBiomagnetics Diagnostics Corp.BiophotonicsbiosensorBusinessCaliforniacholeraClayton Hardmanclinical trialsdefensefluorescenceImagingLos Alamos National LaboratoryLos Alamos National Security LLCmalaria diagnosisOpticsplanar waveguidesprotein-receptor pairsRapidScanSan FranciscoSensors & Detectorstuberculosis

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.